Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
Authors
Keywords
Cancer, Tumours, COVID-19, Immunogenicity, ARNm, SARS-CoV-2 vaccination, Vaccine, Third dose, Heterologous prime-boost vaccination, Double-dose
Journal
EUROPEAN JOURNAL OF CANCER
Volume 154, Issue -, Pages 66-72
Publisher
Elsevier BV
Online
2021-06-18
DOI
10.1016/j.ejca.2021.06.008
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
- (2021) M.C. Garassino et al. ANNALS OF ONCOLOGY
- Vaccination anti COVID-19 pour les personnes souffrant de cancer : un impératif médical et éthique
- (2021) Jean-Philippe Spano et al. BULLETIN DU CANCER
- Current Perspectives: SARS-CoV-2 vaccines for cancer patients: a call to action
- (2021) Chiara Corti et al. EUROPEAN JOURNAL OF CANCER
- SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: recommendations from the French society for Immuno-Therapy of Cancer (FITC)
- (2021) Marie-Léa Gauci et al. EUROPEAN JOURNAL OF CANCER
- Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias
- (2021) Andrew R. Branagan et al. Blood Advances
- Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
- (2021) R. Palich et al. ANNALS OF ONCOLOGY
- Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey
- (2021) J. Barrière et al. ANNALS OF ONCOLOGY
- Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
- (2021) J. Barrière et al. ANNALS OF ONCOLOGY
- Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia
- (2021) Yair Herishanu et al. BLOOD
- Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose
- (2021) Evangelos Terpos et al. BLOOD
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
- (2021) Laura Mansi et al. EUROPEAN JOURNAL OF CANCER
- Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)
- (2021) David Tougeron et al. EUROPEAN JOURNAL OF CANCER
- Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
- (2020) Amit Sud et al. ANNALS OF ONCOLOGY
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Risk factors for COVID-19 severity and mortality among solid cancer patients and its impact on anticancer treatment: a nationwide cohort study (GCO-002 CACOVID-19)
- (2020) Astrid Lièvre et al. EUROPEAN JOURNAL OF CANCER
- Dutch Oncology COVID-19 Consortium (DOCC): outcome of COVID-19 in patients with cancer in a nationwide cohort study
- (2020) K. de Joode et al. EUROPEAN JOURNAL OF CANCER
- COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study
- (2020) Gagandeep Brar et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection
- (2020) QuanQiu Wang et al. JAMA Oncology
- Novel prime-boost vaccine strategies against HIV-1
- (2019) Jean-Louis Excler et al. Expert Review of Vaccines
- A prospective study on the efficacy of two-dose influenza vaccinations in cancer patients receiving chemotherapy
- (2016) Yukinari Sanada et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults
- (2012) D.V. Potsch et al. VACCINE
- Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
- (2011) B. Rousseau et al. ANNALS OF ONCOLOGY
- Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
- (2011) O. E. Yri et al. BLOOD
- Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
- (2009) Sander van Assen et al. ARTHRITIS AND RHEUMATISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started